{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T03:03:01Z","timestamp":1789441381894,"version":"build-2803163510"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,7,31]],"date-time":"2017-07-31T00:00:00Z","timestamp":1501459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,7,31]],"date-time":"2017-07-31T00:00:00Z","timestamp":1501459200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Mental disorders are severe, disabling conditions with unknown etiology and are commonly misdiagnosed when clinical symptomology criteria are solely used. Our previous work indicated that combination of serum levels of multiple proteins in tissue plasminogen activator (tPA)-brain-derived neurotrophic factor (BDNF) pathway improved accuracy of diagnosis of major depressive disorder (MDD). Here, we measured serum levels of tPA, plasminogen activator inhibitor-1 (PAI-1), BDNF, precursor-BDNF (proBDNF), tropomyosin-related kinase B (TrkB) and neurotrophin receptor p75 (p75NTR) in patients with paranoid schizophrenia (SZ, n\u2009=\u200934), MDD (n\u2009=\u200930), bipolar mania (BM, n\u2009=\u200930), bipolar depression (BD, n\u2009=\u200922), panic disorder (PD, n\u2009=\u200930), and healthy controls (HCs, n\u2009=\u200930) by Enzyme-linked immunosorbent assay kits. We used receiver operating characteristic (ROC) curve to analyze diagnostic potential of these proteins. We found, compared with HCs, that serum tPA and proBDNF were lower in SZ, BM and BD; TrkB was lower in SZ and BD; and p75NTR was declined in SZ and BM. ROC analysis showed that combined serum level of tPA, PAI-1, BDNF, proBDNF, TrkB and p75NTR was better than any single protein in accuracy of diagnosis and differentiation, suggesting that the combination of multiple serum proteins levels in tPA-BDNF pathway may have a potential for a diagnostic panel in mental disorders.<\/jats:p>","DOI":"10.1038\/s41598-017-06832-6","type":"journal-article","created":{"date-parts":[[2017,7,25]],"date-time":"2017-07-25T09:34:32Z","timestamp":1500975272000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":44,"title":["Combined serum levels of multiple proteins in tPA-BDNF pathway may aid the diagnosis of five mental disorders"],"prefix":"10.1038","volume":"7","author":[{"given":"Suzhen","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haitang","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenhua","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingying","family":"Yue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuying","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinghui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodong","family":"Mou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chongyang","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxiu","family":"Sui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifeng","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianhua","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinhua","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingsong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huanxin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonggui","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,7,31]]},"reference":[{"key":"6832_CR1","unstructured":"Cross-national comparisons of the prevalences and correlates of mental disorders. WHO International Consortium in Psychiatric Epidemiology. Bull. World. Health. Organ. 78, 413-426 (2000)."},{"key":"6832_CR2","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1177\/070674370605100206","volume":"51","author":"JM Somers","year":"2006","unstructured":"Somers, J. M., Goldner, E. M., Waraich, P. & Hsu, L. Prevalence and incidence studies of anxiety disorders: a systematic review of the literature. Can. J. Psychiatry. \n                           51, 100\u2013113 (2006).","journal-title":"Can. J. Psychiatry."},{"key":"6832_CR3","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1177\/070674370404900208","volume":"49","author":"P Waraich","year":"2004","unstructured":"Waraich, P., Goldner, E. M., Somers, J. M. & Hsu, L. Prevalence and incidence studies of mood disorders: a systematic review of the literature. Can. J. Psychiatry. \n                           49, 124\u2013138 (2004).","journal-title":"Can. J. Psychiatry."},{"key":"6832_CR4","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1371\/journal.pmed.0020141","volume":"2","author":"S Saha","year":"2005","unstructured":"Saha, S., Chant, D., Welham, J. & McGrath, J. A Systematic Review of the Prevalence of Schizophrenia. PLoS. Med. \n                           2, 653\u2013661 (2005).","journal-title":"PLoS. Med."},{"key":"6832_CR5","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.1016\/S0140-6736(09)60660-7","volume":"373","author":"MR Phillips","year":"2009","unstructured":"Phillips, M. R. et al. Prevalence, treatment, and associated disability of mental disorders in four provinces in China during 2001-05: an epidemiological survey. Lancet (London, England). \n                           373, 2041\u20132053 (2009).","journal-title":"Lancet (London, England)."},{"key":"6832_CR6","doi-asserted-by":"publisher","first-page":"e116820","DOI":"10.1371\/journal.pone.0116820","volume":"10","author":"HA Whiteford","year":"2015","unstructured":"Whiteford, H. A., Ferrari, A. J., Degenhardt, L., Feigin, V. & Vos, T. The global burden of mental, neurological and substance use disorders: an analysis from the Global Burden of Disease Study 2010. PLoS One \n                           10, e116820 (2015).","journal-title":"PLoS One"},{"issue":"Suppl 1","key":"6832_CR7","doi-asserted-by":"crossref","first-page":"S133","DOI":"10.1038\/sj.bjp.0707658","volume":"153","author":"E Schwarz","year":"2008","unstructured":"Schwarz, E. & Bahn, S. The utility of biomarker discovery approaches for the detection of disease mechanisms in psychiatric disorders. Brit. J. Pharmacol. \n                           153(Suppl 1), S133\u2013S136 (2008).","journal-title":"Brit. J. Pharmacol."},{"key":"6832_CR8","doi-asserted-by":"publisher","first-page":"2331","DOI":"10.1016\/j.neubiorev.2012.12.007","volume":"37","author":"P Willner","year":"2013","unstructured":"Willner, P., Scheel-Kruger, J. & Belzung, C. The neurobiology of depression and antidepressant action. Neurosci. Biobehav. Rev. \n                           37, 2331\u20132371 (2013).","journal-title":"Neurosci. Biobehav. Rev."},{"key":"6832_CR9","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1093\/schbul\/sbm057","volume":"33","author":"E Vieta","year":"2007","unstructured":"Vieta, E. & Phillips, M. L. Deconstructing bipolar disorder: a critical review of its diagnostic validity and a proposal for DSM-V and ICD-11. Schizophrenia. Bull. \n                           33, 886\u2013892 (2007).","journal-title":"Schizophrenia. Bull."},{"key":"6832_CR10","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1007\/s00702-007-0742-4","volume":"114","author":"S Bender","year":"2007","unstructured":"Bender, S., Weisbrod, M. & Resch, F. Which perspectives can endophenotypes and biological markers offer in the early recognition of schizophrenia? J. Neural. Transm (Vienna). \n                           114, 1199\u20131215 (2007).","journal-title":"J. Neural. Transm (Vienna)."},{"key":"6832_CR11","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1002\/j.2051-5545.2011.tb00004.x","volume":"10","author":"SM Lawrie","year":"2011","unstructured":"Lawrie, S. M., Olabi, B., Hall, J. & McIntosh, A. M. Do we have any solid evidence of clinical utility about the pathophysiology of schizophrenia? World. psychiatry. \n                           10, 19\u201331 (2011).","journal-title":"World. psychiatry."},{"key":"6832_CR12","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1016\/j.jpsychires.2011.03.002","volume":"45","author":"BS Fernandes","year":"2011","unstructured":"Fernandes, B. S. et al. Brain-derived neurotrophic factor as a state-marker of mood episodes in bipolar disorders: a systematic review and meta-regression analysis. J. Psychiatr. Res. \n                           45, 995\u20131004 (2011).","journal-title":"J. Psychiatr. Res."},{"key":"6832_CR13","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1038\/mp.2013.105","volume":"19","author":"ML Molendijk","year":"2014","unstructured":"Molendijk, M. L. et al. Serum BDNF concentrations as peripheral manifestations of depression: evidence from a systematic review and meta-analyses on 179 associations (N\u2009=\u20099484). Mol. Psychiatr. \n                           19, 791\u2013800 (2014).","journal-title":"Mol. Psychiatr."},{"key":"6832_CR14","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1038\/mp.2010.88","volume":"16","author":"MJ Green","year":"2011","unstructured":"Green, M. J., Matheson, S. L., Shepherd, A., Weickert, C. S. & Carr, V. J. Brain-derived neurotrophic factor levels in schizophrenia: a systematic review with meta-analysis. Mol. Psychiatr. \n                           16, 960\u2013972 (2011).","journal-title":"Mol. Psychiatr."},{"key":"6832_CR15","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1159\/000328991","volume":"65","author":"TL Huang","year":"2012","unstructured":"Huang, T. L., Hung, Y. Y., Lee, C. T. & Chen, R. F. Serum protein levels of brain-derived neurotrophic factor and tropomyosin-related kinase B in bipolar disorder: effects of mood stabilizers. Neuropsychobiology. \n                           65, 65\u201369 (2012).","journal-title":"Neuropsychobiology."},{"key":"6832_CR16","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1016\/j.jad.2013.03.002","volume":"150","author":"L Zhou","year":"2013","unstructured":"Zhou, L. et al. Upregulation of blood proBDNF and its receptors in major depression. J. Affect. Disorders. \n                           150, 776\u2013784 (2013).","journal-title":"J. Affect. Disorders."},{"key":"6832_CR17","doi-asserted-by":"publisher","first-page":"e199","DOI":"10.4088\/JCP.14m09029","volume":"76","author":"JA Bilello","year":"2015","unstructured":"Bilello, J. A. et al. MDDScore: confirmation of a blood test to aid in the diagnosis of major depressive disorder. J. Clin. Psychiatry. \n                           76, e199\u2013e206 (2015).","journal-title":"J. Clin. Psychiatry."},{"key":"6832_CR18","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.bbi.2015.10.001","volume":"52","author":"F Haenisch","year":"2016","unstructured":"Haenisch, F. et al. Towards a blood-based diagnostic panel for bipolar disorder. Brain. Behav. Immun. \n                           52, 49\u201357 (2016).","journal-title":"Brain. Behav. Immun."},{"key":"6832_CR19","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.neulet.2015.12.019","volume":"612","author":"H Yamamori","year":"2016","unstructured":"Yamamori, H. et al. Assessment of a multi-assay biological diagnostic test for mood disorders in a Japanese population. Neurosci.Lett. \n                           612, 167\u2013171 (2016).","journal-title":"Neurosci.Lett."},{"key":"6832_CR20","doi-asserted-by":"publisher","first-page":"e794","DOI":"10.4088\/JCP.13m08772","volume":"75","author":"P Xiong","year":"2014","unstructured":"Xiong, P. et al. Combining serum protein concentrations to diagnose schizophrenia: a preliminary exploration. J. Clin. psychiatry. \n                           75, e794\u2013e801 (2014).","journal-title":"J. Clin. psychiatry."},{"key":"6832_CR21","unstructured":"Jiang, H. et al. The serum protein levels of tPA-BDNF pathway are implicated in depression and antidepressant treatment. (unpublished)."},{"key":"6832_CR22","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1007\/s11920-013-0425-9","volume":"15","author":"BI Goldstein","year":"2013","unstructured":"Goldstein, B. I. & Young, L. T. Toward clinically applicable biomarkers in bipolar disorder: focus on BDNF, inflammatory markers, and endothelial function. Curr. Psychiat. Rep. \n                           15, 425 (2013).","journal-title":"Curr. Psychiat. Rep."},{"key":"6832_CR23","doi-asserted-by":"publisher","first-page":"102","DOI":"10.5498\/wjp.v6.i1.102","volume":"6","author":"CY Lai","year":"2016","unstructured":"Lai, C. Y. et al. Biomarkers in schizophrenia: A focus on blood based diagnostics and theranostics. World. J. psychiatry. \n                           6, 102\u2013117 (2016).","journal-title":"World. J. psychiatry."},{"key":"6832_CR24","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1111\/j.1600-0447.1994.tb05878.x","volume":"383","author":"IJ Lopez","year":"1994","unstructured":"Lopez, I. J., Frances, A. & Jones, C. Dysthymic disorder: a comparison of DSM-IV and ICD-10 and issues in differential diagnosis. Acta. Psychiatr. Scand. Suppl. \n                           383, 12\u201318 (1994).","journal-title":"Acta. Psychiatr. Scand. Suppl."},{"key":"6832_CR25","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/0924-9338(96)80320-8","volume":"10","author":"S Dollfus","year":"1995","unstructured":"Dollfus, S. & Petit, M. Principal-component analyses of PANSS and SANS-SAPS in schizophrenia: their stability in an acute phase. Eur. psychiatry. \n                           10, 97\u2013106 (1995).","journal-title":"Eur. psychiatry."},{"key":"6832_CR26","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","volume":"23","author":"M Hamilton","year":"1960","unstructured":"Hamilton, M. A rating scale for depression. J. Neurol. Neurosurg. Psychiatry. \n                           23, 56\u201362 (1960).","journal-title":"J. Neurol. Neurosurg. Psychiatry."},{"key":"6832_CR27","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1192\/bjp.133.5.429","volume":"133","author":"RC Young","year":"1978","unstructured":"Young, R. C., Biggs, J. T., Ziegler, V. E. & Meyer, D. A. A rating scale for mania: reliability, validity and sensitivity. Br.J. psychiatry. \n                           133, 429\u2013435 (1978).","journal-title":"Br.J. psychiatry."},{"key":"6832_CR28","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1111\/j.2044-8341.1959.tb00467.x","volume":"32","author":"M Hamilton","year":"1959","unstructured":"Hamilton, M. The assessment of anxiety states by rating. Br. J. Med. Psychol. \n                           32, 50\u201355 (1959).","journal-title":"Br. J. Med. Psychol."},{"key":"6832_CR29","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/S0022-3956(01)00028-0","volume":"35","author":"MK Shear","year":"2001","unstructured":"Shear, M. K. et al. Reliability and validity of the Panic Disorder Severity Scale: replication and extension. J. Psychiatr. Res. \n                           35, 293\u2013296 (2001).","journal-title":"J. Psychiatr. Res."},{"key":"6832_CR30","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/j.jagp.2016.02.052","volume":"24","author":"AT Soares","year":"2016","unstructured":"Soares, A. T. et al. Decreased Brain-Derived Neurotrophic Factor in Older Adults with Bipolar Disorder. Am. J. Geriatr. Psychiatry. \n                           24, 596\u2013601 (2016).","journal-title":"Am. J. Geriatr. Psychiatry."},{"key":"6832_CR31","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.jpsychires.2016.08.004","volume":"83","author":"RB Rocha","year":"2016","unstructured":"Rocha, R. B. et al. Increased BDNF levels after electroconvulsive therapy in patients with major depressive disorder: A meta-analysis study. J. Psychiatr. Res. \n                           83, 47\u201353 (2016).","journal-title":"J. Psychiatr. Res."},{"key":"6832_CR32","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.eurpsy.2016.03.005","volume":"36","author":"J Li","year":"2016","unstructured":"Li, J. et al. Increased serum brain-derived neurotrophic factor levels following electroconvulsive therapy or antipsychotic treatment in patients with schizophrenia. Eur. psychiatry. \n                           36, 23\u201328 (2016).","journal-title":"Eur. psychiatry."},{"key":"6832_CR33","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1097\/WNN.0000000000000089","volume":"29","author":"S Kheirouri","year":"2016","unstructured":"Kheirouri, S., Noorazar, S. G., Alizadeh, M. & Dana-Alamdari, L. Elevated Brain-Derived Neurotrophic Factor Correlates Negatively with Severity and Duration of Major Depressive Episodes. Cogn. Behav. Neurol. \n                           29, 24\u201331 (2016).","journal-title":"Cogn. Behav. Neurol."},{"key":"6832_CR34","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1186\/s12916-015-0529-7","volume":"13","author":"BS Fernandes","year":"2015","unstructured":"Fernandes, B. S. et al. Peripheral brain-derived neurotrophic factor (BDNF) as a biomarker in bipolar disorder: a meta-analysis of 52 studies. BMC Med. \n                           13, 289 (2015).","journal-title":"BMC Med."},{"key":"6832_CR35","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1038\/mp.2013.172","volume":"19","author":"BS Fernandes","year":"2014","unstructured":"Fernandes, B. S., Berk, M., Turck, C. W., Steiner, J. & Gon, A. C. Decreased peripheral brain-derived neurotrophic factor levels are a biomarker of disease activity in major psychiatric disorders: a comparative meta-analysis. Mol. Psychiatr. \n                           19, 750\u2013751 (2014).","journal-title":"Mol. Psychiatr."},{"key":"6832_CR36","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.jad.2014.11.044","volume":"174","author":"M Polyakova","year":"2015","unstructured":"Polyakova, M. et al. BDNF as a biomarker for successful treatment of mood disorders: a systematic & quantitative meta-analysis. J. Affect. Disorders. \n                           174, 432\u2013440 (2015).","journal-title":"J. Affect. Disorders."},{"key":"6832_CR37","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1038\/mp.2014.117","volume":"20","author":"BS Fernandes","year":"2015","unstructured":"Fernandes, B. S. et al. Peripheral brain-derived neurotrophic factor in schizophrenia and the role of antipsychotics: meta-analysis and implications. Mol. Psychiatr. \n                           20, 1108\u20131119 (2015).","journal-title":"Mol. Psychiatr."},{"key":"6832_CR38","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1038\/mp.2015.54","volume":"21","author":"K Munkholm","year":"2016","unstructured":"Munkholm, K., Vinberg, M. & Kessing, L. V. Peripheral blood brain-derived neurotrophic factor in bipolar disorder: a comprehensive systematic review and meta-analysis. Mol. Psychiatr. \n                           21, 216\u2013228 (2016).","journal-title":"Mol. Psychiatr."},{"key":"6832_CR39","doi-asserted-by":"crossref","unstructured":"Chiou, Y. J. & Huang, T. L. Serum brain-derived neurotrophic factors in Taiwanese patients with drug-naive first-episode schizophrenia: Effects of antipsychotics. World. J. Biol. Psychiatry. 1\u201310 (2016).","DOI":"10.1080\/15622975.2016.1224925"},{"key":"6832_CR40","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1159\/000444220","volume":"97","author":"R Gupta","year":"2016","unstructured":"Gupta, R. et al. Effect of Mirtazapine Treatment on Serum Levels of Brain-Derived Neurotrophic Factor and Tumor Necrosis Factor-alpha in Patients of Major Depressive Disorder with Severe Depression. Pharmacology. \n                           97, 184\u2013188 (2016).","journal-title":"Pharmacology."},{"key":"6832_CR41","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.neulet.2003.08.004","volume":"351","author":"E Shimizu","year":"2003","unstructured":"Shimizu, E. et al. Serum brain-derived neurotrophic factor (BDNF) levels in schizophrenia are indistinguishable from controls. Neurosci. Lett. \n                           351, 111\u2013114 (2003).","journal-title":"Neurosci. Lett."},{"key":"6832_CR42","doi-asserted-by":"publisher","first-page":"132","DOI":"10.4103\/2319-4170.113229","volume":"36","author":"YY Hung","year":"2013","unstructured":"Hung, Y. Y. & Huang, T. L. Lower serum tropomyosin receptor kinase B levels in patients with schizophrenia. Biomedical. journal. \n                           36, 132\u2013136 (2013).","journal-title":"Biomedical. journal."},{"key":"6832_CR43","doi-asserted-by":"publisher","first-page":"535","DOI":"10.3109\/15622975.2011.587892","volume":"13","author":"ML Molendijk","year":"2012","unstructured":"Molendijk, M. L. et al. Gender specific associations of serum levels of brain-derived neurotrophic factor in anxiety. World. J. Bio. Psychiatry. \n                           13, 535\u2013543 (2012).","journal-title":"World. J. Bio. Psychiatry."},{"key":"6832_CR44","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1016\/j.pnpbp.2005.04.010","volume":"29","author":"K Kobayashi","year":"2005","unstructured":"Kobayashi, K. et al. Serum brain-derived neurotrophic factor (BDNF) levels in patients with panic disorder: as a biological predictor of response to group cognitive behavioral therapy. Prog. Neuro-Psychoph. \n                           29, 658\u2013663 (2005).","journal-title":"Prog. Neuro-Psychoph."},{"key":"6832_CR45","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1016\/j.pnpbp.2010.02.021","volume":"34","author":"YY Hung","year":"2010","unstructured":"Hung, Y. Y., Lin, C. J. & Huang, T. L. Higher serum tropomyosin-related kinase B protein level in major depression. Prog. Neuro-Psychoph. \n                           34, 610\u2013612 (2010).","journal-title":"Prog. Neuro-Psychoph."},{"key":"6832_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jad.2014.01.009","volume":"160","author":"DK S\u00f6dersten","year":"2014","unstructured":"S\u00f6dersten, D. K. et al. Abnormality in serum levels of mature brain-derived neurotrophic factor (BDNF) and its precursor proBDNF in mood-stabilized patients with bipolar disorder: a study of two independent cohorts. J. Affect. Disorders. \n                           160, 1\u20139 (2014).","journal-title":"J. Affect. Disorders."},{"key":"6832_CR47","doi-asserted-by":"crossref","unstructured":"Yoshimura, R., Hori, H., Katsuki, A., Atake, K. & Nakamura, J. Serum levels of brain-derived neurotrophic factor (BDNF), proBDNF and plasma 3-methoxy-4-hydroxyphenylglycol levels in chronic schizophrenia. Ann. Gen. Psychiatr. 15 (2016).","DOI":"10.1186\/s12991-015-0084-9"},{"key":"6832_CR48","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1055\/s-0033-1357505","volume":"39","author":"S Hoirisch-Clapauch","year":"2013","unstructured":"Hoirisch-Clapauch, S. & Nardi, A. E. Multiple roles of tissue plasminogen activator in schizophrenia pathophysiology. Semin. Thromb. Hemost. \n                           39, 950\u2013954 (2013).","journal-title":"Semin. Thromb. Hemost."},{"key":"6832_CR49","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.schres.2008.03.004","volume":"103","author":"E Carrizo","year":"2008","unstructured":"Carrizo, E. et al. Coagulation and inflammation markers during atypical or typical antipsychotic treatment in schizophrenia patients and drug-free first-degree relatives. Schizophr. Res. \n                           103, 83\u201393 (2008).","journal-title":"Schizophr. Res."},{"key":"6832_CR50","first-page":"214","volume":"26","author":"D Lasi","year":"2014","unstructured":"Lasi, D. et al. Metabolic syndrome and inflammation markers in patients with schizophrenia and recurrent depressive disorder. Psychiat. Danub. \n                           26, 214\u2013219 (2014).","journal-title":"Psychiat. Danub."},{"key":"6832_CR51","first-page":"71","volume":"27","author":"D Lasi","year":"2015","unstructured":"Lasi, D., Ugle, I. B., Vujnovi, Z. & Krni, S. PAI-1 as a component of the metabolic syndrome in depression and schizophrenia - Croatian experience. Psychiat. Danub. \n                           27, 71\u201372 (2015).","journal-title":"Psychiat. Danub."},{"key":"6832_CR52","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/S0165-1781(02)00005-7","volume":"109","author":"F Karege","year":"2002","unstructured":"Karege, F. et al. Decreased serum brain-derived neurotrophic factor levels in major depressed patients. Psychiat. Res. \n                           109, 143\u2013148 (2002).","journal-title":"Psychiat. Res."},{"key":"6832_CR53","doi-asserted-by":"crossref","unstructured":"Zhao G. et al. Ratio of mBDNF to proBDNF for Differential Diagnosis of Major Depressive Disorder and Bipolar Depression. Mol. Neurobiol. (2016).","DOI":"10.1007\/s12035-016-0098-6"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-06832-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-06832-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-06832-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T07:47:23Z","timestamp":1671781643000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-06832-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,31]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["6832"],"URL":"https:\/\/doi.org\/10.1038\/s41598-017-06832-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,31]]},"assertion":[{"value":"8 February 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"6871"}}